Paridocaine

This classification denotes an anesthetic agent with the molecular formula C17H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 795182TM5G, chemically known as benzoic acid, p-(butylamino)-, 1-methyl-4-piperidyl ester but generally known as paridocaine, which bears US NIH Compound Identifier 23551. European Medicines Agency schedules Paridocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09628MIG. The term PARIDOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). PARIDOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule paridocaine under HS 29333999 and SITC 51574. As of Q4 2014, PARIDOCAINE remains the US FDA Preferred Term for this commodity. Paridocaine bears US NLM identifiers UMLS ID C1882291 and NCI Concept Code C66324. SMILES: O(C1CCN(CC1)C)C(=O)C1CCC(NCCCC)CC1.